Health care workers are exposed to high-risk environments when patients infected with COVID-19 require advanced airway management. The virus tends to be transmitted in the…
Important scientific questions have been raised about data reported in the paper by Mandeep Mehra et al—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
There is a COVID-19 pandemic. We aimed to describe the characteristics of patients transported by the Royal Flying Doctor Service (RFDS) for confirmed or suspected…
Transmission of Coronavirus disease 2019 (COVID-19) within families and
close contacts accounts for the majority of epidemic growth.
Recent coronavirus disease 2019 (COVID-19) events have presented challenges to health care systems worldwide. Air medical movement of individuals with potential infectious disease poses unique challenges…
In late 2019, a novel coronavirus was identified as the cause of a cluster of atypical pneumonia cases in Wuhan, China. It subsequently spread throughout…
A study published in the Lancet May 22, shows increased mortality for patients that got these drugs, compared to the control group.
The COVID-19 crisis is an unprecedented event. It is therefore essential for dispatch centres to share their experiences while the crisis is underway, similar to…
Early identification of patients with novel corona virus disease 2019 (COVID-19) who may develop critical illness is of great importance and may aid in delivering…
Two thirds of ventilated COVID-19 patients require vasopressor support. Recommended vasopressors include norepinephrine and vasopressin.